Jun 2026 (Q2 FY26) — Aug 4, 2026
Kimberly-Clark Q2 FY26 — Solid Productivity Offsets China Diaper Disruption and Macro Headwinds
Read the full callKimberly Clark earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 4,189 | +0.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 15.1 | +0.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 345 | −32.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
6 of 8 judged targets kept · 37 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year capital spending | around $1 billion to $1.2 billion | Mar 2025 | we accelerate capital investments in our growth and transformation plans to approximately $1.3 billion, up from $1.1 billion last year | Achieved |
| Quarterly organic sales growth | slightly below the first quarter's 2.5% | Mar 2026 | Q2 organic net sales were broadly flat | Missed |
| Full-year adjusted earnings per share attributable to Kimberly-Clark | in line with 2025 levels | Dec 2025 | For adjusted EPS attributable to Kimberly-Clark, we now expect a low single-digit decline on a constant currency basis compared with our prior outlook for results to be in line with 2025 levels | Revised Down |
2 of KIMBERLY CLARK CORP's 45 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 42 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $121.44 on 17 Oct 2025 → $105.41. High $121.44 (17 Oct 2025), low $93.05 (7 Apr 2026).
Overview
Guidance
6 of 8 judged targets kept · 37 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year capital spending | around $1 billion to $1.2 billion | Mar 2025 | we accelerate capital investments in our growth and transformation plans to approximately $1.3 billion, up from $1.1 billion last year | Achieved |
| Quarterly organic sales growth | slightly below the first quarter's 2.5% | Mar 2026 | Q2 organic net sales were broadly flat | Missed |
| Full-year adjusted earnings per share attributable to Kimberly-Clark | in line with 2025 levels | Dec 2025 | For adjusted EPS attributable to Kimberly-Clark, we now expect a low single-digit decline on a constant currency basis compared with our prior outlook for results to be in line with 2025 levels | Revised Down |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 45 tracked commitments, with each call’s wording and source.
Call summaries
Kimberly-Clark Q2 FY26 — Solid Productivity Offsets China Diaper Disruption and Macro Headwinds
Read the full callKimberly-Clark Corporation Q1 FY26 — Strong Organic Growth and Kenvue Integration Progress
Read the full callKimberly-Clark Q4 FY25 — Strong Volume-Plus-Mix Growth and Strategic Acquisitions
Read the full callEvery analysed call
Financials
Net profit, year on year: −32% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4,144 | 4,104 | 4,054 | 4,163 | 4,150 | 4,080 | 4,163 | 4,189 |
| Operating profit | 1,026 | 548 | 631 | 592 | 621 | 507 | 753 | 633 |
| Operating margin | 24.8% | 13.3% | 15.6% | 14.2% | 15.0% | 12.4% | 18.1% | 15.1% |
| Interest | 67 | 64 | 64 | 67 | 65 | 60 | 58 | 53 |
| Profit before tax | 962 | — | 557 | 513 | 546 | 436 | 685 | 572 |
| Tax rate | 19.4% | — | 23.5% | 22.6% | 45.4% | 23.9% | 23.9% | 37.9% |
| Net profit | 907 | 447 | 567 | 509 | 446 | 499 | 665 | 345 |
| EPS ($ per share) | 2.70 | 1.34 | 1.71 | 1.53 | 1.34 | 1.50 | 2 | 1.04 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 473 | 473 | 473 | 473 | 473 | 473 | 473 | 473 |
| Reserves | 5,947 | 6,686 | 7,567 | 7,858 | 8,201 | 8,368 | 9,257 | 9,611 |
| Total liabilities | 14,564 | 15,089 | 16,654 | 17,100 | 17,270 | 16,276 | 15,571 | 15,468 |
| Fixed assets | 7,159 | 7,450 | 8,042 | 8,097 | 7,885 | 7,913 | 6,284 | 6,775 |
| Total assets | 14,518 | 15,283 | 17,523 | 17,837 | 17,970 | 17,344 | 16,546 | 17,098 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2,970 | 2,736 | 3,729 | 2,730 | 2,733 | 3,542 | 3,234 | 2,777 |
| Cash from investing | -902 | -1,042 | -2,305 | -1,056 | -785 | -418 | -100 | -951 |
| Cash from financing | -2,115 | -1,792 | -1,567 | -1,696 | -1,760 | -2,374 | -3,166 | -2,179 |
| Net cash flow | -77 | -97 | -139 | -33 | 157 | 666 | -72 | -320 |
| Capital expenditure | -877 | -1,209 | -1,217 | -1,007 | -876 | -766 | -721 | -1,138 |
| Free cash flow | 2,093 | 1,527 | 2,512 | 1,723 | 1,857 | 2,776 | 2,513 | 1,639 |
| Segment | Q2 FY2024 | Q3 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| North America NA | — | — | 55% | 66% | 65% | 80% | 64% | 64% | -1.2% |
| International Personal Care IPC | — | — | 29% | 34% | 35% | 44% | 36% | 36% | +4.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
85 filings between Oct 31, 2025 and Jul 31, 2026.
Purchases
$1.04M
1 purchase by 1 insider
Sales
$1.01M
4 sales by 2 insiders
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| MACLIN TODD | $1.04M | — | Feb 9, 2026 |
| Scribner Andrew | — | $719.3K | May 6, 2026 |
| Chen Katy | — | $288.4K | May 4, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | Slavtcheff Craig Chief R&D Officer | Option exercise | 4,024 | $0 |
| Jul 31, 2026 | Corsi Patricia Chief Growth Officer | Tax withheld | 404 | $44.2K |
| Jul 31, 2026 | Slavtcheff Craig Chief R&D Officer | Tax withheld | 534 | $58.4K |
| Jul 31, 2026 | Corsi Patricia Chief Growth Officer | Option exercise | 966 | $0 |
| Jul 31, 2026 | Slavtcheff Craig Chief R&D Officer | Option exercise | 1,255 | $0 |
| Jul 31, 2026 | Slavtcheff Craig Chief R&D Officer | Tax withheld | 1,711 | $187.0K |
| May 6, 2026 | Scribner Andrew Controller, VP & FP&A | Sale | 4,095 | $401.3K |
| May 4, 2026 | Chen Katy President, Int'l Personal Care | Sale | 1,596 | $152.2K |
| May 1, 2026 | Melucci Jeffrey P. Chief Bus., Strat. & Admin. | Tax withheld | 1,183 | $115.5K |
| May 1, 2026 | Melucci Jeffrey P. Chief Bus., Strat. & Admin. | Option exercise | 3,004 | $0 |
| May 1, 2026 | Urdaneta Nelson Chief Financial Officer | Option exercise | 3,337 | $0 |
| May 1, 2026 | Urdaneta Nelson Chief Financial Officer | Tax withheld | 1,314 | $128.3K |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Option exercise | 2,582 | $0 |
| May 1, 2026 | Melucci Jeffrey P. Chief Bus., Strat. & Admin. | Tax withheld | 1,199 | $117.1K |
| May 1, 2026 | Urdaneta Nelson Chief Financial Officer | Option exercise | 3,384 | $0 |
| May 1, 2026 | Hsu Michael D. Chairman of the Board and CEO | Tax withheld | 4,128 | $403.2K |
| May 1, 2026 | Abou-Oaf Ehab Pres. Int'l Fam. Care & Prof. | Option exercise | 1,450 | $0 |
| May 1, 2026 | Torres Russell President and COO | Option exercise | 4,158 | $0 |
| May 1, 2026 | Hsu Michael D. Chairman of the Board and CEO | Option exercise | 10,490 | $0 |
| May 1, 2026 | Torres Russell President and COO | Option exercise | 3,146 | $0 |
| May 1, 2026 | Torres Russell President and COO | Tax withheld | 1,239 | $121.0K |
| May 1, 2026 | Hsu Michael D. Chairman of the Board and CEO | Tax withheld | 4,377 | $427.5K |
| May 1, 2026 | McGee Grant B General Counsel & Secretary | Tax withheld | 457 | $44.6K |
| May 1, 2026 | Melucci Jeffrey P. Chief Bus., Strat. & Admin. | Option exercise | 3,046 | $0 |
| May 1, 2026 | Scribner Andrew Controller, VP & FP&A | Tax withheld | 160 | $15.6K |
| May 1, 2026 | Urdaneta Nelson Chief Financial Officer | Tax withheld | 1,332 | $130.1K |
| May 1, 2026 | McGee Grant B General Counsel & Secretary | Tax withheld | 451 | $44.0K |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Option exercise | 1,450 | $0 |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Option exercise | 1,430 | $0 |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Tax withheld | 637 | $62.2K |
| May 1, 2026 | Scribner Andrew Controller, VP & FP&A | Option exercise | 655 | $0 |
| May 1, 2026 | Scribner Andrew Controller, VP & FP&A | Option exercise | 665 | $0 |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Tax withheld | 1,151 | $112.4K |
| May 1, 2026 | Fenske Tamera Chief Supply Chain Officer | Tax withheld | 647 | $63.2K |
| May 1, 2026 | McGee Grant B General Counsel & Secretary | Option exercise | 1,144 | $0 |
| May 1, 2026 | Scribner Andrew Controller, VP & FP&A | Tax withheld | 162 | $15.8K |
| May 1, 2026 | Slavtcheff Craig Chief R&D Officer | Option exercise | 1,257 | $0 |
| May 1, 2026 | Slavtcheff Craig Chief R&D Officer | Tax withheld | 535 | $52.3K |
| May 1, 2026 | McGee Grant B General Counsel & Secretary | Option exercise | 1,160 | $0 |
| May 1, 2026 | Abou-Oaf Ehab Pres. Int'l Fam. Care & Prof. | Option exercise | 1,430 | $0 |
| May 1, 2026 | Corsi Patricia Chief Growth Officer | Option exercise | 966 | $0 |
| May 1, 2026 | Corsi Patricia Chief Growth Officer | Tax withheld | 403 | $39.4K |
| May 1, 2026 | Chen Katy President, Int'l Personal Care | Option exercise | 1,740 | $0 |
| May 1, 2026 | Chen Katy President, Int'l Personal Care | Option exercise | 1,716 | $0 |
| May 1, 2026 | Hsu Michael D. Chairman of the Board and CEO | Option exercise | 11,122 | $0 |
| May 1, 2026 | Torres Russell President and COO | Tax withheld | 1,637 | $159.9K |
| Apr 30, 2026 | Chen Katy President, Int'l Personal Care | Sale | 1,405 | $136.2K |
| Apr 26, 2026 | Fenske Tamera Chief Supply Chain Officer | Tax withheld | 839 | $82.1K |
| Apr 26, 2026 | Fenske Tamera Chief Supply Chain Officer | Option exercise | 1,882 | $0 |
| Apr 26, 2026 | Fenske Tamera Chief Supply Chain Officer | Award | 10,585 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow KIMBERLY CLARK CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Nearest to Kimberly Clark by market cap among the sector's top 20 companies at Q2 2026.